Literature DB >> 15465592

Mimotopes of conformational epitopes in fibrillar beta-amyloid.

Goar Gevorkian1, Irina Petrushina, Karen Manoutcharian, Anahit Ghochikyan, Gonzalo Acero, Vitaly Vasilevko, David H Cribbs, Michael G Agadjanyan.   

Abstract

In Alzheimer's disease (AD) beta-amyloid peptide accumulates in the brain in different forms including fibrils. Amyloid fibrils could be recognized as foreign by the mature immune system since they are not present during its development. Thus, using mouse antisera raised against the fibrillar form of Abeta42, we have screened two phage peptide libraries for the presence of foreign conformational mimotopes of Abeta. Antisera from wild type animals recognized predominately peptides with the EFRH motif from Abeta42 sequence, whereas amyloid precursor protein (APP) transgenic mice recognized mainly phage clones that mimic epitopes (mimotopes) within the fibrillar Abeta42 but lack sequence homology with this peptide.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465592     DOI: 10.1016/j.jneuroim.2004.06.004

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  6 in total

1.  Linear and conformation specific antibodies in aged beagles after prolonged vaccination with aggregated Abeta.

Authors:  Vitaly Vasilevko; Viorela Pop; Hyun Jin Kim; Tommy Saing; Charles C Glabe; Saskia Milton; Edward G Barrett; Carl W Cotman; David H Cribbs; Elizabeth Head
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

2.  Anti-11[E]-pyroglutamate-modified amyloid β antibodies cross-react with other pathological Aβ species: relevance for immunotherapy.

Authors:  Roxanna Perez-Garmendia; Vanessa Ibarra-Bracamontes; Vitaly Vasilevko; Jose Luna-Muñoz; Raul Mena; Tzipe Govezensky; Gonzalo Acero; Karen Manoutcharian; David H Cribbs; Goar Gevorkian
Journal:  J Neuroimmunol       Date:  2010-09-22       Impact factor: 3.478

3.  Abeta-immunotherapy for Alzheimer's disease using mannan-amyloid-Beta peptide immunoconjugates.

Authors:  Anahit Ghochikyan; Irina Petrushina; Andrew Lees; Vitaly Vasilevko; Nina Movsesyan; Adrine Karapetyan; Michael G Agadjanyan; David H Cribbs
Journal:  DNA Cell Biol       Date:  2006-10       Impact factor: 3.311

4.  Molecular basis for passive immunotherapy of Alzheimer's disease.

Authors:  Anna S Gardberg; Lezlee T Dice; Susan Ou; Rebecca L Rich; Elizabeth Helmbrecht; Jan Ko; Ronald Wetzel; David G Myszka; Paul H Patterson; Chris Dealwis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-25       Impact factor: 11.205

5.  Phage display and peptide mapping of an immunoglobulin light chain fibril-related conformational epitope.

Authors:  Brian O'Nuallain; Amy Allen; Demet Ataman; Deborah T Weiss; Alan Solomon; Jonathan S Wall
Journal:  Biochemistry       Date:  2007-10-18       Impact factor: 3.162

6.  Immunodominant epitope and properties of pyroglutamate-modified Abeta-specific antibodies produced in rabbits.

Authors:  G Acero; K Manoutcharian; V Vasilevko; M E Munguia; T Govezensky; G Coronas; A Luz-Madrigal; D H Cribbs; G Gevorkian
Journal:  J Neuroimmunol       Date:  2009-07-09       Impact factor: 3.478

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.